Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Medicine News
NIH-sponsored trial of nasal COVID-19 vaccine begins enrollment
A first-in-human trial of a nasal COVID-19 vaccine candidate began enrolling adults aged 18 to 64 years who have received at least three prior doses of a COVID-19 messenger RNA vaccine, according to the NIH.
More real-world evidence shows nirsevimab protects infants against RSV
The monoclonal antibody nirsevimab reduced the risk that infants would be hospitalized for respiratory syncytial virus-associated bronchiolitis, according to a study published Wednesday in The New England Journal of Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
CDC: Fourth US dairy farm worker tests positive for bird flu
A dairy farm worker in Colorado became the fourth person to test positive for avian influenza in the ongoing outbreak affecting dairy cows in the United States, the CDC announced Wednesday.
Should the CDC do away with shared clinical decision-making?
Rather than telling a patient they should get a vaccine, the CDC’s shared clinical decision-making recommendations advise patients to speak to providers about certain vaccines and decide on an individual basis if they should receive them.
US gives Moderna $176 million to develop mRNA pandemic flu vaccine
HHS announced that it will give Moderna around $176 million to accelerate the development of a messenger RNA-based pandemic influenza vaccine amid an ongoing outbreak of avian influenza.
Will new approvals, stronger recommendations improve RSV vaccine uptake?
After decades of RSV vaccine development, the approvals and recommendations were seen as landmark events in preventive medicine. Uptake was low, however — not unusual for first-year approvals, experts told Healio.
Q&A: Could vaccinating birds, cows stop bird flu outbreak?
Avian influenza continues to be detected among birds and dairy cows in the United States, raising questions about how to control the more than 2-year-old outbreak.
CDC recommends new COVID-19, pneumococcal vaccines
The CDC on Thursday recommended updated COVID-19 vaccines for the 2024-2025 respiratory season, and a newly approved 21-valent pneumococcal conjugate vaccine for adults.
CDC universally recommends RSV vaccines for oldest US adults
The CDC’s vaccine advisors voted unanimously Wednesday to recommend that everyone aged 75 years or older get vaccinated against respiratory syncytial virus.
Top in ID: FDA approves adult pneumococcal vaccine; Healio interviews CDC director
The FDA has approved Capvaxive, Merck’s 21-valent pneumococcal vaccine, which is specifically made to protect adults.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read